Tradestie Institutional Equity Comparison Engine

REPL vs ENTA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

REPL Overall Edge

REPL Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Replimune Group, Inc. (REPL) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ENTA counters with relative strength in Valuation. Fundamentally, REPL trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ENTA at 44.0x Forward P/E and -90.0% operating margin (-21.6% YoY). In options structure, REPL sits in BREAKOUT (8th %ile IV; Dealer Gamma Walls on Pro) against ENTA sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ENTA
REPL N/M vs ENTA 44.0x Fwd P/E
Growth & Margin Winner REPL
Op Margin 0.0% vs -90.0% ยท YoY +0.0% vs -21.6%
Momentum & Technical Winner REPL
1Y +138.5% vs -7.9% ยท 52W Pos 91% vs 10%
Options & Structure Winner REPL
BREAKOUT (8th %ile IV) vs BREAKDOWN (11th %ile IV)
REPL NASDAQ
Replimune Group, Inc.
Biological Products, (No Disgnostic Substances)
$21.56
-1.51% 1D
Market Cap $2.1B
1M Return +98.53%
1Y Return +138.5%
Forward P/E N/M
Unified AI Score
27.4 / 100 SELL
Tech 50.0 Fund 34.0 Flow 67.0 Mom 50.0
ENTA NASDAQ
Enanta Pharmaceuticals, Inc
Pharmaceutical Preparations
$10.79
-1.82% 1D
Market Cap $326.2M
1M Return -2.79%
1Y Return -7.94%
Forward P/E 44.0x
Unified AI Score
46.2 / 100 HOLD
Tech 53.0 Fund 54.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: REPL +138.5% ENTA -7.94% Spread: +148.03 pp (REPL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
REPL TTM Op. Margin: 0.0% ENTA TTM Op. Margin: -90.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on REPL vs ENTA. Trailing 12-month operating profitability (REPL 0.0% vs ENTA -90.0%) and valuation multiples (REPL N/M vs ENTA 44.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: REPL (5) vs ENTA (5)
Institutional Metric REPL ENTA Criterion Row Winner
Market Capitalization Scale $2.1B $326.2M Larger Scale REPL
Trailing P/E Ratio Valuation N/M 44.0x Lower Multiple ENTA
Forward P/E Ratio Valuation N/M 44.0x Lower Multiple ENTA
Revenue Growth (YoY) Growth +0.0% -21.6% Higher Growth REPL
Operating Margin (TTM) Profitability 0.0% -90.0% Higher Margin REPL
Net Profit Margin Profitability 0.0% -96.9% Higher Margin REPL
Return on Equity (ROE) Capital Efficiency -115.8% -70.1% Higher ROE ENTA
52-Week Range Position Momentum 91% ($2โ€“$24) 10% ($10โ€“$17) Stronger Trend REPL
Beta / 30D Volatility Risk Regime 2.09ฮฒ ยท 100% Vol 0.89ฮฒ ยท 58% Vol Lower Realized Risk ENTA
Unified Institutional Score Composite Signal 27.4 / 100 (SELL) 46.2 / 100 (HOLD) Higher Composite ENTA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full REPL vs ENTA Buy Guide
REPL BREAKOUT
98d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live REPL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENTA BREAKDOWN
95d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live ENTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither REPL nor ENTA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.